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Abstract: An imbalance between matrix metalloproteases (MMPs) and the tissue 
inhibitors of metalloproteases (TIMPs) may have a negative impact on the healing of 
rotator cuff tears. The aim of the project was to assess a possible relationship between 
clinical and radiographic characteristics of patients such as the age, sex, as well as the 
degenerative status of the tendon and the MMPs and TIMPs in their tenocyte-like cells 
(TLCs). TLCs were isolated from ruptured supraspinatus tendons and quantitative  
Real-Time PCR and ELISA was performed to analyze the expression and secretion of 
MMPs and TIMPs. In the present study, MMPs, mostly gelatinases and collagenases such 
as MMP-2, -9 and -13 showed an increased expression and protein secretion in TLCs of 
donors with higher age or degenerative status of the tendon. Furthermore, the expression 
and secretion of TIMP-1, -2 and -3 was enhanced with age, muscle fatty infiltration and 
tear size. The interaction between MMPs and TIMPs is a complex process, since TIMPs 
are not only inhibitors, but also activators of MMPs. This study shows that MMPs and 
TIMPs might play an important role in degenerative tendon pathologies. 
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1. Introduction 
Matrix metalloproteases (MMPs) are a large family of proteolytic enzymes, which can degrade all 
components of the extracellular tendon matrix [1,2]. Their activities are antagonized by the interaction 
with the tissue inhibitors of metalloproteases (TIMPs). The balance between MMPs and TIMPs plays  
a critical role in tendon degeneration and healing [3,4]. The healing after rotator cuff (RC) 
reconstruction is associated with high failure rates [5–7], mainly linked to the formation of inferior, 
disorganized scar tissue at the tendon bone insertion site [8,9]. The mechanisms underlying the poor 
tendon healing are widely unknown. Since the MMPs and TIMPs regulate tendon modeling and 
remodeling, it is hypothesized that the development of tendon pathologies is dependent on the 
MMP/TIMP balance [2,10]. 
MMPs are classified according to their substrate specificity, sequence similarity and domain 
organization into the six groups [11]. Collagenases like MMP-1, MMP-8, MMP-13, and MMP-18 
primarily degrade the most important component of the tendon matrix, the collagens [12,13].  
The gelatinases MMP-2 and MMP-9 mainly degrade smaller collagen fragments and gelatin.  
The stromelysins MMP-3, MMP-10, and MMP-11; the matrilysins MMP-7 and MMP-26; and  
the metalloelastase (MMP-12) primarily degrade glycoproteins and proteoglycans [1,13]. The group of 
membrane bound MMPs (including MMP-14 and MMP-17) has a regulatory function and can activate 
other MMPs [2,14]. 
The activity of MMPs is highly regulated by four endogenous antagonists (TIMP-1 to TIMP-4), 
which can inhibit all MMPs by the formation of stoichiometric complexes through a non-covalent 
interaction with a zinc-binding site in the MMPs. TIMPs are not specific to any single MMP group and 
their inhibitory effects are overlapping [15]. Notably, TIMPs do not only inhibit the active forms of 
MMPs, but also interfere with the latent form and regulate their activation process. Thus, TIMPs can 
have promoting as well as inhibitory effects on the regulation of cell growth, invasion, differentiation, 
apoptosis and angiogenesis [16,17]. 
The aim of the project was to examine the expression and secretion of MMPs and TIMPs in 
tenocyte-like cells (TLCs) of Supraspinatus (SSP) tendon tears from donors differing in their 
degenerative status, age and sex. We hypothesize that the donor characteristics influence the MMP and 
TIMP expression and secretion in the TLCs, which might lead to an imbalanced MMP/TIMP ratio in 
the donor risk groups. 
2. Results and Discussions 
2.1. Correlation of Donor Characteristics 
First, correlations between the individual parameters of the radiographic examination were 
investigated. Strong correlations were observed between muscle fatty infiltration (MFI) and tendon 
retraction (rs = 0.769, p < 0.001) and tear size (rs = 0.607, p < 0.001) as well as between tendon 
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retraction and tear size (rs = 0.690, p < 0.001). Subsequently, correlations between radiographic 
parameters and age were evaluated. The MFI showed strong correlation with the age (rs = 0.673,  
p < 0.001), whereas mild age-dependent associations were observed for tear size (rs = 0.463, p = 0.011) 
and tendon retraction (rs = 0.411, p = 0.024). 
2.2. Average MMP and TIMP Expression and Protein Secretion over All Samples (n = 30) 
Gene expression analysis revealed MMP-2 expression to be the strongest in all TLCs, followed by 
MMP-3 and MMP-1. MMP-9, -10, and -13 were expressed in very low amounts, whereas MMP-10 
and MMP-13 were only expressed in 26 or 28 samples, respectively. High expression levels of  
TIMP-1, -2 and -3 were found in all cells, while the TIMP-4 mRNA expression was much weaker 
(Figure 1). Due to the weak expression of MMP-9, -10 and -13, these MMPs were not analyzed on 
protein level. For the rest of the MMPs and TIMPs, the protein analysis of cell culture supernatants 
revealed a comparable pattern, where MMP-2 was the most secreted MMP and TIMP-1 and -2 the 
most secreted TIMPs in the cells (Figure 2). The FCS containing medium, which served as negative 
control, did not show detectable levels of MMPs or TIMPs in any of the ELISA analysis. 
 
Figure 1. MMP and TIMP mRNA expression of all samples. Quantitative Real-Time PCR 
(qRT-PCR) analysis from torn RC tendons. The data represent the relative gene expression 
with 18S as reference gene using the ΔCt method with efficiency correction. Data are 
expressed as the mean ± SD (n = 30) given in logarithmic form. MMP-2, TIMP-1, -2,  
and -3 showed the highest expression levels, while MMP-9, -10, and -13 showed  
lowest expression. 




Figure 2. MMP and TIMP protein secretion of all samples. MMP-2 and TIMP-1 data were 
derived from sandwich ELISA. All other proteins were analyzed using Multiplex ELISA 
technique. All values were normalized to the total protein content (Coomassie Plus assay), 
given as mean ± SD (n = 30) represented in a logarithmic graph. MMP-2, TIMP-1, and -2 
protein secretion was strongest in the cells, while MMP-1, -3, and TIMP-4 protein 
secretion was lower. 
2.3. Relationship between Donor Characteristics and MMP/TIMP Expression and Secretion 
Results of MMP/TIMP expression at mRNA and protein level did not differ significantly between 
TLCs of male and female donors. Therefore, all 30 TLC cultures were analyzed without separation 
regarding the donor sex. 
To determine the influence of donor age, donors were segregated into two groups: under 65 years  
(n = 16) and over 65 years (n = 14). The analysis revealed an age-dependent increase in the  
mRNA-expression levels of MMP-2, -9, -13 and TIMP-2, -3 (Figure 3A). This could only be 
confirmed at the protein level for MMP-2. In addition, protein levels of TIMP-1 were significantly 
elevated in TLCs from older donors, while mRNA expression was unaltered (Figure 3B). Spearman’s 
rho correlation revealed mild correlations between the age and the mRNA levels of MMP-2 
(Spearman’s rank correlation coefficient (rs) = 0.504; p = 0.005), TIMP-2 (rs = 0.485; p = 0.007), and 
TIMP-3 (rs = 0.455; p = 0.012) (Table 1). 




Figure 3. MMPs and TIMPs grouped according to the age of the donors (under 65 years  
(n = 16) and over 65 years (n = 14)). (A) qRT-PCR was performed to analyze gene 
expression. The box plot data represent the relative gene expression with 18S as reference 
gene using the ΔCt method with efficiency correction. The mRNA levels of MMP-2, -9,  
-13 and TIMP-2, -3 are significantly increased with higher age; (B) Protein levels were 
analyzed using ELISA and normalized to total protein content (Coomassie Plus assay). 
Protein levels of MMP-2 and TIMP-1 were significantly elevated with higher age. To 
allow visualization of all MMPs/TIMPs in one figure, MMP-9 and -13 values were 
multiplied by 105. 
Table 1. Correlations between donor characteristics and MMPs and TIMPs. 
Items  
Relative Gene Expression Protein Secretion 
MMP-2 MMP-9 MMP-10 MMP-13 TIMP-2 TIMP-3 MMP-1 TIMP-1 TIMP-2 
Age 
rs 0.504 
- - - 
0.485 0.455 
- - - 





- - - - - 
0.413 
- 










0.451 −0.451 0.460 
- - 
0.416 0.526 0.413 
p-value 0.012 0.012 0.010 0.022 0.003 0.023 
To analyze the association between MMP/TIMP expression and MFI, patients were grouped as 
follows: score 0–1 (n = 10) and score 2–4 (n = 20). The mRNA levels of MMP-2, -9 and TIMP-3 were 
significantly increased in TLCs from donors with enhanced MFI (Figure 4). At the protein level, none 
of the investigated proteins showed a significant alteration. MFI correlated mildly with mRNA values 
of MMP-9 (rs = 0.432; p = 0.017) and protein values of TIMP-1 (rs = 0.413; p = 0.023) (Table 1). 




Figure 4. MMPs and TIMPs grouped according to the MFI (low MFI: Goutallier score 0–1 
(n = 10); high MFI: Goutallier score 2–4 (n = 20)). qRT-PCR was performed to analyze 
gene expression. The box plot data represent the relative gene expression with 18S as 
reference gene using the ΔCt method with efficiency correction. In the high MFI group 
increasing gene expression for MMP-2, -9 and TIMP-3 occurred. To allow a visualization 
of all MMPs/TIMPs in one figure, MMP-9 values were multiplied by 105. 
Tendon retraction was analyzed using two distinct groups: patients with the score of 0–1 (n = 9) 
versus patients with the score of 2–3 (n = 20). At mRNA and protein levels, no significant differences 
could be found between the two groups (data not shown). Nevertheless, tendon retraction showed mild 
correlation with protein secretion of TIMP-2 (rs = 0.407; p = 0.029) (Table 1). 
Groups for analysis of the tear size were set as follows: score 1–2 (n = 12) and score 3–4 (n = 18). 
At mRNA level, MMP-9 and -13 were significantly enhanced in TLCs from donors with bigger tear 
size, whereas MMP-10 showed significantly decreased expression rates. At protein level, MMP-1 and  
TIMP-1 were significantly higher expressed with bigger tear size (Figure 5). A mild correlation was 
found between tear size and mRNA values of MMP-9 (rs = 0.451; p = 0.012) and MMP-13 (rs = 0.460; 
p = 0.010) and a mild negative correlation with MMP-10 (rs = −0.451; p = 0.012). At protein level tear 
size correlated mildly with MMP-1 (rs = 0.416; p = 0.022), TIMP-1 (rs = 0.526; p = 0.003), and  
TIMP-2 (rs = 0.413; p = 0.023) (Table 1).  




Figure 5. MMPs and TIMPs grouped according to the tear size (small tear size: Bateman 
score 1–2 (n = 12); big tear size: Bateman score 3–4 (n = 18)). (A) qRT-PCR was 
performed to analyze gene expression. The box plot data represent the relative gene 
expression with 18S as reference gene using the ΔCt method with efficiency correction. 
MMP-9, and -13 expression of donors with bigger tear size was significantly increased, 
while MMP-10 expression was decreased at mRNA level; and (B) Protein levels were 
analyzed using ELISA and normalized to total protein content (Coomassie Plus assay). 
Protein level of MMP-1 and TIMP-1 showed an elevated secretion with bigger tear size. 
To allow a visualization of all MMPs/TIMPs in one figure, MMP-1 values were multiplied 
by 102 and MMP-9, -10 and -13 by 105. 
2.4. Discussion 
The healing of RC tears depends on the patient characteristic as well as the tendon tissue quality. 
However, the cellular or molecular mechanisms behind this relationship are still elusive. We 
previously showed that TLCs isolated from donors differing in age, sex and MFI exhibit different 
cellular characteristics and stimulation potential with BMP-2 and BMP-7 [18–20]. Since MMPs and 
TIMPs represent the main regulators of modeling and remodeling in the tendon, it was the aim to 
assess their expression and secretion in TLCs and their supernatant, related to the age, sex and 
degenerative status of the tendon. We hypothesized a change of the expression and secretion of MMPs 
and TIMPs in TLCs of risk groups, which might lead to an imbalance and therefore might explain the 
weaker healing potential in these patient groups. 
In fact, we observed a predominately increased expression and secretion of MMPs and TIMPs in 
TLCs of older donors and of donors with higher degenerative status of the tendon.The most prominent 
changes within the MMPs were found for the gelatinases MMP-2 and MMP-9. Gelatinases such as 
MMP-2 and -9 mainly degrade smaller collagen fragments or already degraded collagen (gelatin) [21]. 
Since tears of the RC are mainly due to degeneration, this may indicate an important role of the 
Int. J. Mol. Sci. 2015, 16 13148 
 
 
gelatinases in later steps of the degeneration process after the full collagen structure was already 
degraded by other MMPs such as the collagenases. Within the TIMPs, mostly TIMP-1, -2 and -3 were 
regulated with donor characteristics. 
In the present study, no difference in expression or secretion of MMPs and TIMPs were found 
between TLCs of male and female donors. Estrogen was reported to increase MMP-13 expression in 
rat Achilles tendon cells when directly applied to the cells [22]. Hormones such as Estrogen may not 
play a major role when they are not directly added to the cells. However, it has to be kept in mind that 
the FCS in the medium contains an undefined amount of hormones and the phenolred, which is present 
in the cell culture medium, can act as a weak Estrogen mimic [23]. Since tenocytes of male and female 
donors were shown to express Estrogen receptors [24], both components might influence the TLCs of 
male and female donors in the same manner. 
The age of the donors is an important factor influencing the healing outcome after RC surgery and  
a cut off is mainly described at the age of 60 to 65 years [7,25]. In the present study, with an age cut 
off at 65 years, a significantly enhanced expression and secretion of MMP-2, -9 and -13 as well as  
TIMP-1, -2 and -3 was found and confirmed by correlation analysis. Results for MMP-2 and -9 are in 
accordance with Yu et al. who found the same changes in rat Achilles tenocytes [26]. In contrast to our 
findings, a decreased expression of TIMP-1 and TIMP-2 was reported. This is probably due to 
differences in experimental parameters such as donor species and age [26]. Similarly, another group 
reported increased MMP-1 activity in SSP tendons of elderly donors [10]. However, this was not observed 
in the present study. 
The SSP tendon has a high collagen turnover, which is linked to high MMP activity levels in the 
tendon [10]. MMP-1, MMP-2, MMP-3, MMP-9, MMP-10 and MMP-13 are mainly described in the 
context of tendon healing. However, direct comparisons are critical, since most studies analyzed 
differences in MMP/TIMP expression between healthy and ruptured tendons using tissue sections and 
not cultured TLCs from ruptured RC tendons with different degeneration. MFI is a predictor for high 
degenerative status of tendons. Here, we found that enhanced MFI is correlated with significantly 
increased expression of MMP-2 and -9 in TLCs. A high MFI is the result of a barely moved shoulder 
due to the tendon rupture and insufficient mechanical stimulation of the tendon [27]. As mechanical 
stimulation was reported to influence MMP expression in rat tenocytes [28], this might explain 
possible alterations of MMPs with increasing MFI. A bigger tear size was found to be positively 
correlated with the increase in RNA levels of MMP-9 and -13 and protein level of MMP-1. These 
findings are in line with other studies, showing increased expression of these MMPs in ruptured 
Achilles or RC tendons compared to intact controls [10,29,30]. In contrast, Castagna et al. described 
no changes in protein levels of MMPs and TIMPs between SSP tendons of a torn area versus a 
macroscopically healthy area and the intact subscapularis tendon in 13 patients [31]. A recent study 
reports that the MMP-9 expression is associated with tendon retraction [30]. In contrast, others found  
a decreased gelatinolytic activity (MMP-2, MMP-9 and MMP-13) in ruptured SSP tendons compared 
to normal tendons [10]. MMP-3 was presently neither regulated on RNA nor protein level regarding 
the degenerative status of the tendon or other donor characteristics. Contradictory findings were 
observed by other authors, who reported that MMP-3 expression was mostly downregulated in ruptured 
or tendinopathic tendons [10,29,30]. It was hypothesized that the role of MMP-3 as an activator of other 
MMPs is important to bear a correct remodeling process [10]. 
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In general, an increased MMP activity on the in vivo level could cause an imbalance between 
MMPs and TIMPs, which might lead to an excessive degradation of the tendon extracellular matrix 
and therefore to an inferior healing. It is clinically observed that the healing after RC reconstructions is 
often inferior in patients with higher age or degenerative status [25,27,32]. These clinical findings  
may be a result of increased activity of MMPs, as found presently. However, beyond the MMPs  
also TIMP-1, -2 and -3 were increased with higher age, MFI, and tear size. An increased TIMP-1 
expression in the healing SSP tendon of rats was also described by Choi et al. [33]. Additionally,  
an elevated TIMP-1 level in plasma samples was found in patients with full thickness tears of the  
RC [34]. Other studies described that TIMP-2, TIMP-3 and TIMP-4 expression was decreased in 
ruptured Achilles or RC tendons compared to intact controls [29,35]. The presently observed increased 
TIMP expression and secretion might be a direct response of the cells to prevent an elevated MMP 
activity in their microenvironment. However, it is not clear if tendon rupture or degenerative changes 
are either cause or consequence of altered MMP/TIMP expression and activity levels. It was described 
that a failed healing investigated more than six months after RC reconstructions correlated with  
an increased MMP-1 and MMP-9 expression analyzed at the time of surgery which indicates that  
the biological environment at the time of surgery may directly influence the healing outcome [36]. 
Additionally, TIMPs are not only inhibitors of MMPs, but are also able to regulate the activation of 
MMPs [14]. Furthermore, this might explain the increased amounts of TIMPs and underlines the 
complex process of interaction between MMPs and TIMPs. 
With the knowledge that an imbalance between MMPs/TIMPs in a tissue may challenge its healing 
capacity, it can be hypothesized that the use of MMP inhibitors could improve tendon healing.  
This hypothesis was examined previously by injecting substance P, an inhibitor of endopeptidases,  
in operative Achilles tendon repair in rats, which resulted in improved biomechanical properties [37]. 
Other studies used the MMP inhibitors doxycycline and α-2-macroglobulin for the repair of SSP 
tendons in rats and found decreased collagen degradation and improved collagen organization and 
biomechanical competence of regenerated tissues [38,39]. However, broad-spectrum MMP inhibitors 
as therapeutic agent have to be used with caution. Since MMPs are involved in various other functions 
in the body, they might cause undesired side effects. The goal would therefore be to develop more 
selective MMP inhibitors [40]. 
2.5. Limitations of the Study 
TLCs were cultured in medium containing 10% heat inactivated FCS. FCS contains growth factors 
as well as some MMPs, which might have influenced the MMP and TIMP expression and secretion in 
the TLCs. However, the FCS was heat inactivated, which reduces the growth factor concentration as 
well as MMPs, as described for human plasma samples [41]. Furthermore, all cells were cultured 
identically, which should have affected all cells in the same manner. 
Culturing primary cells in 2D culture is always a critical point, due to the risk of differentiation. 
Analyzing RNA directly isolated from the tendon tissue would avoid this problem, but is very 
challenging because of the limited biopsy size and RNA available. Therefore, only cells at very low 
passages (passages 1 and 2) were used to minimize differentiation problems. Mazzocca et al. described 
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that tenocytes cultured in 2D culture can be used within the first three passages until a phenotypic drift 
occurs [42]. 
In the present study, we were not able to fully ensure that pure tenocyte cultures were used for  
the experiments. It might be possible that the presence of immune cells such as macrophages or 
lymphocytes could have affected the results of the study, because they are also able to express MMPs 
and TIMPs. However, as we could show previously, the tenocyte cultures isolated with the same 
method were characterized by flow cytometry analysis and expressed hematopoietic markers (CD11b, 
CD14, CD19, CD34, CD45) in less than 2% [18–20]. Therefore, the presence of immune cells in the 
tenocyte cultures can be nearly ruled out. 
Data regarding the baseline of MMP and TIMP expression in cells of intact tendons would be  
a helpful additional information to validate the findings of the present study. However, SSP samples 
from age-matched patients (43–76 years) will never be totally intact, as RC tendons often undergo 
degenerative changes through age, which might have an effect on the MMPs and TIMPs as well. 
As it is understood that mechanical stimulation plays an important role in the MMP/TIMP 
expression, the static 2D cell culture applied in this study might have had an effect on the MMP and 
TIMP expression and secretion. Furthermore, knowing the movement history of the RC patients prior 
to surgery could improve our study. However, this is not possible, but it can be speculated from the 
MRI data of the SSP muscle that patients with a high MFI have a longer or more severe pain history 
with decreased movement. Additionally to that, it was not possible to examine the period of time when 
the RC tear initially occurred. This is reasonable, because RC tears are mostly of degenerative nature, 
which is a slow process. Even if the patients above 50 years of age had an injury, mostly a 
degenerative pathology preceded [43]. However, there might be a correlation between the time period 
and the MFI as well. 
Within the present study, we concentrated on analyzing the most described MMPs and the TIMPs. 
However, other proteases also play a role in extracellular matrix remodeling and therefore tendon 
healing such as cathepsins, a desintegrin and metalloproteases (ADAMs) or their attendant subgroup a 
desintegrin and metalloprotease with trombospondin motifs (ADAMTs). Therefore, the present study 
can only give a limited insight into the mechanisms of tendon degeneration. 
3. Experimental Section 
3.1. Tendon Material 
TLCs were isolated from SSP tendon biopsies from 16 male and 14 female donors undergoing 
arthroscopic or open shoulder surgery. Biopsies were obtained (3–5 mm) from the proximal edge of 
the torn tendon. All patients gave their written informed consent and the local ethics committee of the 
Charité-Universitaetsmedizin Berlin authorized the anonymous use of tendon samples, which would 
otherwise be discarded (Ethic number: EA1/060/09). 
3.2. Evaluation of Clinical Data 
For each patient, the sex, age, and radiographic scores such as MFI according to Goutallier et al. [44] 
(MRI-assessed [45]), tendon retraction according to Patte et al. [46], and tear size according to  
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Bateman [47] were collected. Beyond this, retrospective patient identification was impossible. Donor 
characteristics are recorded in Table 2. 










1 43 m 0 1 3 
2 46 m 0 0 2 
3 50 m 1 1 1 
4 54 m 0 - 2 
5 55 m 0 1 3 
6 58 m 1 2 4 
7 61 m 3 3 4 
8 62 m 2 2 2 
9 62 m 3 2 2 
10 67 m 2 2 3 
11 68 m 4 3 3 
12 69 m 3 3 4 
13 69 m 4 3 4 
14 70 m 2 2 2 
15 73 m 3 2 2 
16 73 m 2 2 3 
17 48 f 1 1 2 
18 52 f 0 1 1 
19 53 f 0 2 2 
20 60 f 3 3 4 
21 61 f 1 1 2 
22 62 f 3 2 3 
23 63 f 2 2 3 
24 69 f 4 2 4 
25 70 f 2 0 3 
26 71 f 3 3 4 
27 71 f 2 1 2 
28 74 f 2 2 3 
29 75 f 4 2–3 4 
30 76 f 3 3 4 
3.3. Cell Isolation and Culture 
TLCs were isolated by collagenase digestion as described previously. The previous characterization 
study revealed a distinct tenocyte phenotype for cells isolated using this method [48]. Cells were 
cultured with growth medium (DMEM/Ham’s F12 with 10% heat inactivated FCS and 1% 
Penicillin/Streptomycin, all Biochrom AG, Berlin, Germany) at 37 °C, with 95% humidity and 5% 
carbon dioxide, with a medium change three times per week. When TLCs reached a minimum of  
5 × 105 vital cells they were cryo preserved until use. 
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3.4. Gene Expression Analysis 
Cells from each donor (passage 1 or 2) were seeded in three wells of a 6-well plate and cultured 
under standard conditions for 7 days until they grew 80%–90% confluent. RNA was isolated from the 
cells using the NucleoSpin RNA II Kit (Macherey Nagel, Düren, Germany) according to the 
manufacturer. RNA quantity and purity was analyzed with a Nanodrop ND-1000 Spectrophotometer 
(PeqLab Biotechnologie, Erlangen, Germany). A total of 100 ng RNA were transcribed into 
complementary DNA (cDNA) using the qScript cDNA Supermix (Quanta BioSciences, Gaithersburg, 
MD, USA) with the Epgradient Mastercycler (Eppendorf, Hamburg, Germany). As PCR template, 
1.25 ng cDNA were used for the qRT-PCR analysis. The cDNA was diluted 1:3 with Sybr Green 
mastermix (Quanta BioSciences) containing 10 µM of forward and reverse primer mix to a total 
volume of 15.5 µL. All primer sequences were designed using Primer 3 software (Freeware; Available 
online: http://frodo.wi.mit.edu/primer3), and were produced by Tib Molbiol, Berlin, Germany (Primer 
sequences see Table 3). A qRT-PCR program with an initial denaturation step for 3 min at 94 °C was 
used, followed by an amplification program with 40 repeated cycles (95 °C for 15 s, 64.2 °C for 45 s, 
72 °C for 30 s), and a melting curve program. For all primers, amplification efficiencies were analyzed 
and relative gene expression calculated using the ΔCt method with efficiency correction. In previous 
studies 18S was found to be the most stable gene compared to other housekeeping genes in TLCs and 
was therefore used as reference gene. If no gene expression was measurable within amplification,  
the Ct value was set at 37, where only unspecific amplification or primer dimers can be expected. 
Table 3. qRT-PCR Primer. 
Gene Accession No. Primer Sequence Size (bp) 
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Table 3. Cont. 













3.5. Multiplex ELISA 
The protein concentration of the four TIMPs, MMP-1 and MMP-3 in the cell culture supernatant 
was analyzed using Magnetic Luminex Performance Assays (TIMP Multiplex Kit, MMP base kit plus  
MMP-1 and MMP-3 kit, R&D Systems, Abingdon, UK) according to the manufacturer. Briefly, cell 
culture supernatants from three 6-wells were pooled. Standards and pooled supernatants were 
measured in duplicates. Medium with 10% FCS served as negative control. Supernatants were diluted 
1:4 for TIMP assay and used undiluted for MMP-1/MMP-3 assay. An automated magnetic washing 
device (Bio-Plex® Pro II, BioRad Laboratories, Munich, Germany) was used. The assays were 
analyzed using the Bio-Plex® 200 System (BioRad) with the Bio-Plex Manager software. Protein 
concentrations of the TIMPs and MMPs were normalized to the total protein content in the supernatant 
analyzed by Coomassie Plus assay (Thermo Fisher Scientific, Dreieich, Germany). 
3.6. Sandwich ELISA 
TIMP-1 concentration was further analyzed by conventional sandwich ELISA (TIMP-1 DuoSet 
ELISA, R&D Systems). Protein concentration of MMP-2 was analyzed using Total MMP-2 
Quantikine ELISA (R&D Systems) according to the manufacturer instructions. Standards and pooled 
cell culture supernatants were measured in duplicates. Medium with 10% FCS served as negative 
control. Supernatants were diluted 1:4 for MMP-2 ELISA and 1:200 for TIMP-1 ELISA. Protein 
concentrations of TIMP-1 and MMP-2 were normalized to total protein content (Coomassie assay). 
3.7. Statistics 
Statistical analysis was performed using SPSS 20 (IBM, Armonk, NY, USA). For the analysis of 
significant differences between two cohorts, the radiographic scores were grouped as follows: the cut 
off for MFI and tendon retraction was defined between grade 1 and 2, and the cut off for tear size 
between grade 2 and 3. An age cut off was defined at 65 years in accordance with the literature [6,7]. 
Mann-Whitney U test was performed to analyze significant differences between the defined groups. 
The box plots represent the median with 25th to 75th percentile and the whiskers are placedat  
1.5 times the interquartile range below/above the first/third quartile of the box. Spearman’s rho test 
was used for correlation analysis and is given as Spearman’s rank correlation coefficient (rs).  
Statistical dependence between two variables was only considered for correlation values above 0.4.  
A rs of 0.4–0.6 was considered mild, whereas a rs above 0.6 was considered as strong correlation.  
The level of significance was set at p < 0.05. 




In the present in vitro study, TLCs from donors with higher age (>65 years) or degenerative status 
of the tendon showed increased mRNA and protein levels of mainly the gelatinases MMP-2 and  
MMP-9, but also the TIMPs were upregulated in theses donor groups. The interaction between MMPs 
and TIMPs is a complex process, since TIMPs are not only inhibitors of MMPs, but are also able to 
regulate the activation of MMPs. The results of the present study show that MMPs and TIMPs might 
play an important role in degenerative tendon pathologies, but also highlights the need of more 
knowledge in this research area. 
Acknowledgments 
We thank Levent Akyüz for the excellent assistance with the Bio-Plex® System. We thank the 
German Society for Surgery of the Shoulder and the Elbow (DVSE) and the European Society for 
Surgery of the Shoulder and the Elbow (ESSSE) for the financial support of the study. The study was 
furthermore partially supported by the Federal Ministry of Education and Research (BMBF, 
FKZ1315848A) and the Deutsche Forschungsgemeinschaft (DFG) through funding of the BCRT and 
the Research Unit 2165. 
Author Contributions 
Substantial contributions to research design, or the acquisition, analysis or interpretation of data: 
Franka Klatte-Schulz, Thomas Aleyt, and Britt Wildemann; Drafting the paper or revising it critically: 
Franka Klatte-Schulz, Stephan Pauly, Sven Geißler, Christian Gerhardt, Markus Scheibel, and  
Britt Wildemann; Approval of the submitted and final version: all authors. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Vincenti, M.P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase 
(TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and  
cell-type-specific expression. Methods Mol. Biol. 2001, 151, 121–148. 
2. Del Buono, A.; Oliva, F.; Longo, U.G.; Rodeo, S.A.; Orchard, J.; Denaro, V.; Maffulli, N. 
Metalloproteases and rotator cuff disease. J. Shoulder Elbow Surg. 2012, 21, 200–208. 
3. Dalton, S.; Cawston, T.E.; Riley, G.P.; Bayley, I.J.; Hazleman, B.L. Human shoulder tendon 
biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases.  
Ann. Rheum. Dis. 1995, 54, 571–577. 
4. Magra, M.; Maffulli, N. Matrix metalloproteases: A role in overuse tendinopathies. Br. J. Sports Med. 
2005, 39, 789–791. 
  
Int. J. Mol. Sci. 2015, 16 13155 
 
 
5. Chillemi, C.; Petrozza, V.; Garro, L.; Sardella, B.; Diotallevi, R.; Ferrara, A.; Gigante, A.;  
di Cristofano, C.; Castagna, A.; della Rocca, C. Rotator cuff re-tear or non-healing: 
Histopathological aspects and predictive factors. Knee Surg. Sports Traumatol. Arthrosc. 2011, 
19, 1588–1596. 
6. Charousset, C.; Bellaiche, L.; Kalra, K.; Petrover, D. Arthroscopic repair of full-thickness rotator 
cuff tears: Is there tendon healing in patients aged 65 years or older? Arthroscopy 2010, 26,  
302–309. 
7. Boileau, P.; Brassart, N.; Watkinson, D.J.; Carles, M.; Hatzidakis, A.M.; Krishnan, S.G. 
Arthroscopic repair of full-thickness tears of the supraspinatus: Does the tendon really heal?  
J. Bone Jt. Surg. Am. 2005, 87, 1229–1240. 
8. Gerber, C.; Schneeberger, A.G.; Perren, S.M.; Nyffeler, R.W. Experimental rotator cuff repair.  
A preliminary study. J. Bone Jt. Surg. Am. 1999, 81, 1281–1290. 
9. Koike, Y.; Trudel, G.; Curran, D.; Uhthoff, H.K. Delay of supraspinatus repair by up to 12 weeks 
does not impair enthesis formation: A quantitative histologic study in rabbits. J. Orthop. Res. 
2006, 24, 202–210. 
10. Riley, G.P.; Curry, V.; DeGroot, J.; van El, B.; Verzijl, N.; Hazleman, B.L.; Bank, R.A.  
Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon 
pathology. Matrix Biol. 2002, 21, 185–195. 
11. Kasper, G.; Glaeser, J.D.; Geissler, S.; Ode, A.; Tuischer, J.; Matziolis, G.; Perka, C.; Duda, G.N. 
Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal 
stem cell behavior. Stem Cells 2007, 25, 1985–1994. 
12. Nagase, H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 1997, 378, 151–160. 
13. Birkedal-Hansen, H.; Moore, W.G.; Bodden, M.K.; Windsor, L.J.; Birkedal-Hansen, B.; DeCarlo, A.; 
Engler, J.A. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 1993, 4, 197–250. 
14. Glaeser, J.D.; Geissler, S.; Ode, A.; Schipp, C.J.; Matziolis, G.; Taylor, W.R.; Knaus, P.;  
Perka, C.; Duda, G.N.; Kasper, G. Modulation of matrix metalloprotease-2 levels by mechanical 
loading of three-dimensional mesenchymal stem cell constructs: Impact on in vitro tube 
formation. Tissue Eng. Part A 2010, 16, 3139–3148. 
15. Gomez, D.E.; Alonso, D.F.; Yoshiji, H.; Thorgeirsson, U.P. Tissue inhibitors of metalloproteinases: 
Structure, regulation and biological functions. Eur. J. Cell Biol. 1997, 74, 111–122. 
16. Brew, K.; Dinakarpandian, D.; Nagase, H. Tissue inhibitors of metalloproteinases: Evolution, 
structure and function. Biochim. Biophys. Acta 2000, 1477, 267–283. 
17. Chirco, R.; Liu, X.W.; Jung, K.K.; Kim, H.R. Novel functions of timps in cell signaling.  
Cancer Metastasis Rev. 2006, 25, 99–113. 
18. Klatte-Schulz, F.; Pauly, S.; Scheibel, M.; Greiner, S.; Gerhardt, C.; Schmidmaier, G.; Wildemann, B. 
Influence of age on the cell biological characteristics and the stimulation potential of male human 
tenocyte-like cells. Eur. Cells Mater. 2012, 24, 74–89. 
19. Klatte-Schulz, F.; Gerhardt, C.; Scheibel, M.; Wildemann, B.; Pauly, S. Relationship between 
muscle fatty infiltration and the biological characteristics and stimulation potential of tenocytes 
from rotator cuff tears. J. Orthop. Res. 2014, 32, 129–137. 
Int. J. Mol. Sci. 2015, 16 13156 
 
 
20. Klatte-Schulz, F.; Pauly, S.; Scheibel, M.; Greiner, S.; Gerhardt, C.; Hartwig, J.; Schmidmaier, G.; 
Wildemann, B. Characteristics and stimulation potential with BMP-2 and BMP-7 of tenocyte-like 
cells isolated from the rotator cuff of female donors. PLoS ONE 2013, 8, e67209. 
21. Klein, T.; Bischoff, R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 
2011, 41, 271–290. 
22. Irie, T.; Takahata, M.; Majima, T.; Abe, Y.; Komatsu, M.; Iwasaki, N.; Minami, A. Effect of 
selective estrogen receptor modulator/raloxifene analogue on proliferation and collagen 
metabolism of tendon fibroblast. Connect. Tissue Res. 2010, 51, 179–187. 
23. Berthois, Y.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S. Phenol red in tissue culture media is 
a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture.  
Proc. Natl. Acad. Sci. USA 1986, 83, 2496–2500. 
24. Bridgeman, J.T.; Zhang, Y.; Donahue, H.; Wade, A.M.; Juliano, P.J. Estrogen receptor expression 
in posterior tibial tendon dysfunction: A pilot study. Foot Ankle Int. 2010, 31, 1081–1084. 
25. Cho, N.S.; Lee, B.G.; Rhee, Y.G. Arthroscopic rotator cuff repair using a suture bridge technique: 
Is the repair integrity actually maintained? Am. J. Sports Med. 2011, 39, 2108–2116. 
26. Yu, T.Y.; Pang, J.H.; Wu, K.P.; Chen, M.J.; Chen, C.H.; Tsai, W.C. Aging is associated with 
increased activities of matrix metalloproteinase-2 and -9 in tenocytes. BMC Musculoskelet. Disord. 
2013, 14, doi:10.1186/1471-2474-14-2. 
27. Gladstone, J.N.; Bishop, J.Y.; Lo, I.K.; Flatow, E.L. Fatty infiltration and atrophy of the rotator 
cuff do not improve after rotator cuff repair and correlate with poor functional outcome. Am. J. 
Sports Med. 2007, 35, 719–728. 
28. Maeda, E.; Fleischmann, C.; Mein, C.A.; Shelton, J.C.; Bader, D.L.; Lee, D.A. Functional analysis 
of tenocytes gene expression in tendon fascicles subjected to cyclic tensile strain. Connect. Tissue Res. 
2010, 51, 434–444. 
29. Lo, I.K.; Marchuk, L.L.; Hollinshead, R.; Hart, D.A.; Frank, C.B. Matrix metalloproteinase and 
tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator 
cuff tendons. Am. J. Sports Med. 2004, 32, 1223–1229. 
30. Lakemeier, S.; Braun, J.; Efe, T.; Foelsch, C.; Archontidou-Aprin, E.; Fuchs-Winkelmann, S.; 
Paletta, J.R.; Schofer, M.D. Expression of matrix metalloproteinases 1, 3, and 9 in differing 
extents of tendon retraction in the torn rotator cuff. Knee Surg. Sports Traumatol. Arthrosc. 2011, 
19, 1760–1765. 
31. Castagna, A.; Cesari, E.; Gigante, A.; Conti, M.; Garofalo, R. Metalloproteases and their 
inhibitors are altered in both torn and intact rotator cuff tendons. Musculoskelet. Surg. 2013, 97, 
39–47. 
32. DeFranco, M.J.; Bershadsky, B.; Ciccone, J.; Yum, J.K.; Iannotti, J.P. Functional outcome of 
arthroscopic rotator cuff repairs: A correlation of anatomic and clinical results. J. Shoulder  
Elbow Surg. 2007, 16, 759–765. 
33. Choi, H.R.; Kondo, S.; Hirose, K.; Ishiguro, N.; Hasegawa, Y.; Iwata, H. Expression and 
enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in 
rabbits. J. Orthop. Res. 2002, 20, 927–933. 
34. Hallgren, H.C.; Eliasson, P.; Aspenberg, P.; Adolfsson, L.E. Elevated plasma levels of TIMP-1 in 
patients with rotator cuff tear. Acta Orthop. 2012, 83, 523–528. 
Int. J. Mol. Sci. 2015, 16 13157 
 
 
35. Jones, G.C.; Corps, A.N.; Pennington, C.J.; Clark, I.M.; Edwards, D.R.; Bradley, M.M.;  
Hazleman, B.L.; Riley, G.P. Expression profiling of metalloproteinases and tissue inhibitors of 
metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum. 2006, 54, 
832–842. 
36. Robertson, C.M.; Chen, C.T.; Shindle, M.K.; Cordasco, F.A.; Rodeo, S.A.; Warren, R.F. Failed 
healing of rotator cuff repair correlates with altered collagenase and gelatinase in supraspinatus 
and subscapularis tendons. Am. J. Sports Med. 2012, 40, 1993–2001. 
37. Steyaert, A.E.; Burssens, P.J.; Vercruysse, C.W.; Vanderstraeten, G.G.; Verbeeck, R.M. The 
effects of substance p on the biomechanic properties of ruptured rat achilles’ tendon. Arch. Phys.  
Med. Rehabil. 2006, 87, 254–258. 
38. Bedi, A.; Fox, A.J.; Kovacevic, D.; Deng, X.H.; Warren, R.F.; Rodeo, S.A. Doxycycline-mediated 
inhibition of matrix metalloproteinases improves healing after rotator cuff repair. Am. J. Sports Med. 
2010, 38, 308–317. 
39. Bedi, A.; Kovacevic, D.; Hettrich, C.; Gulotta, L.V.; Ehteshami, J.R.; Warren, R.F.; Rodeo, S.A. 
The effect of matrix metalloproteinase inhibition on tendon-to-bone healing in a rotator cuff repair 
model. J. Shoulder Elbow Surg. 2010, 19, 384–391. 
40. Baker, A.H.; Edwards, D.R.; Murphy, G. Metalloproteinase inhibitors: Biological actions and 
therapeutic opportunities. J. Cell Sci. 2002, 115, 3719–3727. 
41. Ayache, S.; Panelli, M.C.; Byrne, K.M.; Slezak, S.; Leitman, S.F.; Marincola, F.M.; Stroncek, D.F. 
Comparison of proteomic profiles of serum, plasma, and modified media supplements used for 
cell culture and expansion. J. Transl. Med. 2006, 4, 40. 
42. Mazzocca, A.D.; Chowaniec, D.; McCarthy, M.B.; Beitzel, K.; Cote, M.P.; McKinnon, W.;  
Arciero, R. In vitro changes in human tenocyte cultures obtained from proximal biceps tendon: 
Multiple passages result in changes in routine cell markers. Knee Surg. Sports Traumatol. Arthrosc. 
2012, 20, 1666–1672. 
43. Milgrom, C.; Schaffler, M.; Gilbert, S.; van Holsbeeck, M. Rotator-cuff changes in asymptomatic 
adults. The effect of age, hand dominance and gender. J. Bone Jt. Surg. Br. 1995, 77, 296–298. 
44. Goutallier, D.; Postel, J.M.; Bernageau, J.; Lavau, L.; Voisin, M.C. Fatty muscle degeneration in 
cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin. Orthop. Relat. Res. 1994, 78–83. 
45. Fuchs, B.; Weishaupt, D.; Zanetti, M.; Hodler, J.; Gerber, C. Fatty degeneration of the muscles  
of the rotator cuff: Assessment by computed tomography versus magnetic resonance imaging.  
J. Shoulder Elbow Surg. 1999, 8, 599–605. 
46. Patte, D. Classification of rotator cuff lesions. Clin. Orthop. Relat. Res. 1990, 254, 81–86. 
47. Bayne, O.; Bateman, J.E.; Welsch, R.P. Long term results of surgical repair of full thickness 
rotator cuff tears. In Surgery of the Shoulder; Mosby: Philadelphia, PA, USA, 1984; pp. 167–171. 
48. Pauly, S.; Klatte, F.; Strobel, C.; Schmidmaier, G.; Greiner, S.; Scheibel, M.; Wildemann, B.  
BMP-2 and BMP-7 affect human rotator cuff tendon cells in vitro. J. Shoulder Elbow Surg. 2012, 
21, 464–473. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
